Mark K. Oki

Overview

Mark K. Oki received an average of $446K in total compensation, including $299K in salary, at AYTU BIOPHARMA between 2022 and 2023. Mark Oki also received an average of $541K at VIVUS from 2015 to 2018.

Related executives

We found 25 more executives who work or worked at AYTU BIOPHARMA and VIVUS.

Joshua Disbrow

AYTU BIOPHARMA

Chief Executive Officer

Greg Pyszczymuka

AYTU BIOPHARMA

Chief Commercial Officer since January

David Green

AYTU BIOPHARMA

Chief Financial Officer

Richard Eisenstadt

AYTU BIOPHARMA

Chief Financial Officer

since Green

AYTU BIOPHARMA

Chief Financial Officer

Jarrett Disbrow

AYTU BIOPHARMA

Chief Operating Officer

John Amos

VIVUS

Chief Executive Officer

Kenneth Suh

VIVUS

President

News

You may also like